Xcellerant Ventures

Lenoss Medical is attending the LSI USA Emerging Medtech Summit this week in Dana Point, California. Swing by, talk with Dom Messerli, MBA and John M. Williams to learn about #OsteoPearl, a biological solution for Osteoporotic Vertebral Compression Fractures. Placing Natural bone where More bone is needed most #vcf #osteoporosis #spine #bonehealth #MedTech #LSIUSA2025

It’s nearly here! ? #SunDevilGiving Day is March 20 and thanks to our generous partners at Xcellerant Ventures, Monsoon Venture Fund and DCA Asset Management, Inc. your gift will be matched dollar for dollar, up to $1,000 for the fund! It’s time to change the narrative for ASU students interested in venture capital. Your support will provide hands-on learning experiences and career development opportunities through ASU InvestU and ASU ScaleU. Donate here: https://lnkd.in/gb8tEHq4

We spoke with James Bates, CEO of AdviNOW Medical, about transforming healthcare efficiency with AI. Here are the key go-to-market lessons from their journey: → Use engineering methods to uncover hidden opportunities. AdviNOW conducted Six Sigma analysis of medical clinics, revealing that physicians spend 2/3 of their time on tasks they weren't required to do - a massive inefficiency traditional market research missed. → Target where profitability creates urgency. They focused on urgent care centers with "single digit EBITDA" margins rather than chasing large hospital systems immediately. This beachhead market had both acute pain and decision-making autonomy. → Turn regulatory complexity into competitive advantage. Instead of seeing healthcare regulations as obstacles, AdviNOW built them into their core value proposition, creating AI that handles both medical knowledge and compliance requirements. → Structure strategic investments for distribution. They brought in medical equipment companies as investors, creating natural distribution channels through partnership rather than building them from scratch. → Map the real incentive structures. AdviNOW discovered that insurance companies were incentivized to increase revenue due to profit caps - a crucial insight that shaped their solution design and positioning. → Position as enhancement, not disruption. Their messaging focused on augmenting physician capabilities rather than replacing them, creating an "everybody wins" narrative that accelerated adoption in a conservative industry. These insights from AdviNOW Medical show how deep system analysis and stakeholder alignment can unlock opportunities in regulated industries. Listen to the full conversation with James Bates on Category Visionaries to learn more about their approach to healthcare innovation here: https://lnkd.in/eznA7vVm #Healthcare #Innovation #StartupLessons #B2B #AIinHealthcare

How do venture capital firms assess companies and make investment decisions? Vikram Chaudhery, PhD, Partner at Genoa Ventures, will participate in a panel discussion about this topic next week at the 2025 Flinn Foundation Bio Capital Conference. With a career spanning business leadership, life sciences investment, and entrepreneurial innovation, Vikram is consistently involved with merging biology and technology to find new solutions for unmet needs. He’ll join an esteemed panel alongside Janelle Goulard (Partner, Pangaea Ventures), Scott Whyte (Partner, Health Enterprise Partners), and Chris Yoo, PhD (General Partner, Xcellerant Ventures). This session offers a unique opportunity for entrepreneurs and startups to gain an insider perspective on how venture capitalists evaluate potential investments, focusing on key criteria such as the founding team, market potential, and innovative technology. ?? Creighton University Health Sciences Campus, Phoenix ??? March 6, 7:45 a.m. – 4:30 p.m., networking reception after 4:30

?? PSA: Big news! Nanodropper is officially approved as a Class I medical device by the KFDA! ?? This isn’t just a milestone – it’s a revolution in precision eye care. ????? Say goodbye to wasteful drops and hello to accuracy that matters. Ready for the next level in eye health? ?? Join the movement at nanodropper.com #Nanodropper #KFDAApproved #PrecisionEyeCare #InnovationInSight #EyeCareRevolution #TechForGood #HealthInnovation #EyeHealthMatters #SmartTech #MedicalDevice #HealthcareInnovation #FutureOfHealthcare #BetterVision #VisionCare #InstaHealth #TechInnovation

The Flinn Foundation Bio Capital Conference is bringing together investors to discuss what it really takes to secure venture capital funding. On March 6, our GP, Chris Yoo, will be joining an expert panel alongside Vikram Chaudhery (Genoa Ventures & General Inception), Janelle Goulard (Pangaea Ventures), and Scott Whyte (Health Enterprise Partners) to share insights on how VCs evaluate startups. Join the discussion and get an insider’s perspective—register here: https://lnkd.in/gQR935cG #VentureCapital #Biotech #StartupFunding #FlinnFoundation #XcellerantVentures

We are pleased to announce that DeepLook Medical has joined the ASU InvestU portfolio following a successful fundraise at our November 2024 #healthtech pitch event. Deeplook Medical is enhancing medical imaging to improve the accuracy and effectiveness of cancer care. Thank you to Marissa Fayer, CEO, for participating in the InvestU pitch event and diligence process. Our members were impressed by Fayer's deep market expertise and passion for health equity. We were proud to partner with Xcellerant Ventures for this event and are excited to foster more collaboration between angel investors and VCs across the Arizona State University ecosystem. #InvestU #startups

Hello Everyone, The Flinn Foundation is co-hosting the 2025 Flinn Foundation Bio Capital Conference (March 6), a collaboration with the Arizona Bioscience Roadmap Risk Capital Team. The goal is to provide an energetic forum for our Bio/Life Science and Healthtech entrepreneurs, investor and venture capital communities and ecosystem builders to connect, network and learn. This year’s theme is “Managing Growth and VC Capital As You Scale,”. We have an exciting lineup of speakers and panelists that includes keynotes from J.P. Morgan's Health Innovation team and serial entrepreneur and founder of Teledoc Health, Michael Gorton Other highlights include a fireside chat with Louis Breton Louis Breton, the co-founder and CEO of Rampart Bioscience (raised $85 million, 2024) discussing the funding journey, its highs and lows, and a behind-the-scene look at how VCs assess companies and investments moderated by Janelle Goulard, partner, Pangaea Ventures with Vikram Chaudhery, Partner, General Inception and Chris Yoo, Xcellerant Ventures Registration is only $50, this includes continental breakfast, lunch, parking, and an after-conference reception. The conference will be hosted at the Creighton University Health Sciences Campus - Phoenix. Visit?flinn.org/bioconference?for the latest updates. If the conference would be of benefit to others in your network, can you pass along the link or send me their contact information and I will reach out. https://lnkd.in/gA4iQ7bQ

This week our CEO Marissa Fayer joined forces with fellow leaders and innovators in women's health for the Women's Health PAC event at the NYSE! Over 150 people came together to learn about the bipartisan opportunities available in women's health. They discussed how sharing personal stories, breaking down taboos, and ensuring adequate health coverage in the workplace can make a significant impact. ?? Ft: Kate Ryder, Founder & CEO of Maven Clinic, Emmy Award Winner & Producer of The M Factor: Shredding the Silence on Menopause, Tamsen Fadal, & Anu Duggal, Founding Partner at Female Founders Fund

Congratulations to our portfolio company, Lenoss Medical, on their success in 2024! We’re excited to see how they build on this momentum and further advance biological solutions for spinal fracture care this year. To learn more about Lenoss Medical, head to www.lenoss.com. #spinehealth #venturecapital #spine #vcf #healthcareinnovation